PLX PHARMA INC (PLXPQ)
Institutional ownership reported to the SEC as of Q2 2026, across 20 quarters.
1
Reporting holders
$0
Reported value
0.0%
Held as options
-1
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Financial Gravity Companies, Inc. | $0 | 1,050 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $0 | 1,050 | 1 | 0 | 0 | 0.0% |
| Q2 2023 | 2 | $161 | 61,483 | 1 | 0 | 0 | 0.0% |
| Q1 2023 | 28 | $456.6K | 3,512,926 | 1 | 3 | 10 | 0.0% |
| Q4 2022 | 30 | $734.7K | 4,467,880 | 7 | 6 | 9 | 0.3% |
| Q3 2022 | 39 | $4.2M | 6,334,031 | 2 | 11 | 13 | 2.1% |
| Q2 2022 | 48 | $20.1M | 7,949,967 | 3 | 9 | 18 | 3.9% |
| Q1 2022 | 50 | $37.2M | 8,760,108 | 8 | 12 | 18 | 4.9% |
| Q4 2021 | 58 | $113.6M | 13,379,725 | 12 | 24 | 10 | 5.7% |
| Q3 2021 | 63 | $197.3M | 9,512,903 | 25 | 25 | 6 | 6.9% |
| Q2 2021 | 45 | $121.9M | 8,455,906 | 18 | 15 | 4 | 4.5% |
| Q1 2021 | 35 | $64.5M | 7,134,676 | 21 | 8 | 2 | 0.2% |
| Q4 2020 | 16 | $11.7M | 2,120,666 | 3 | 2 | 3 | 0.0% |
| Q3 2020 | 14 | $6.6M | 2,054,946 | 2 | 2 | 1 | 0.0% |
| Q2 2020 | 14 | $6.5M | 2,012,805 | 2 | 0 | 5 | 0.0% |
| Q1 2020 | 15 | $4.6M | 2,046,660 | 1 | 5 | 1 | 0.0% |
| Q4 2019 | 18 | $8.9M | 2,036,131 | 3 | 3 | 3 | 0.0% |
| Q3 2019 | 14 | $10.0M | 1,969,970 | 2 | 5 | 3 | 0.0% |
| Q2 2019 | 17 | $13.9M | 1,935,697 | 3 | 5 | 1 | 0.0% |
| Q1 2019 | 17 | $11.3M | 2,157,810 | 5 | 2 | 3 | 0.0% |
| Q4 2018 | 13 | $3.2M | 2,120,671 | 0 | 0 | 0 | 0.0% |